233 related articles for article (PubMed ID: 23095282)
1. Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis.
Mäki-Petäjä KM; Elkhawad M; Cheriyan J; Joshi FR; Ostör AJ; Hall FC; Rudd JH; Wilkinson IB
Circulation; 2012 Nov; 126(21):2473-80. PubMed ID: 23095282
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB
Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987
[TBL] [Abstract][Full Text] [Related]
3. Response to letter regarding article, ''anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis''.
Circulation; 2013 Jul; 128(1):e11. PubMed ID: 23980280
[No Abstract] [Full Text] [Related]
4. Letter by Lensen et al regarding article, "anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis".
Lensen KJ; van Sijl AM; Smulders YM
Circulation; 2013 Jul; 128(1):e10. PubMed ID: 23817487
[No Abstract] [Full Text] [Related]
5. Subclinical vasculitis as a potential mechanism to explain the heightened cardiovascular risk in rheumatoid arthritis.
Fayad ZA; Greenberg JD; Bucerius J
Circulation; 2012 Nov; 126(21):2449-51. PubMed ID: 23095281
[No Abstract] [Full Text] [Related]
6. The effect of tumor necrosis factor-α antagonists on arterial stiffness in rheumatoid arthritis: a literature review.
Dulai R; Perry M; Twycross-Lewis R; Morrissey D; Atzeni F; Greenwald S
Semin Arthritis Rheum; 2012 Aug; 42(1):1-8. PubMed ID: 22475245
[TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis.
Van Doornum S; McColl G; Wicks IP
Rheumatology (Oxford); 2005 Nov; 44(11):1428-32. PubMed ID: 16076882
[TBL] [Abstract][Full Text] [Related]
8. Etanercept normalises left ventricular mass in patients with rheumatoid arthritis.
Daïen CI; Fesler P; du Cailar G; Daïen V; Mura T; Dupuy AM; Cristol JP; Ribstein J; Combe B; Morel J
Ann Rheum Dis; 2013 Jun; 72(6):881-7. PubMed ID: 22872022
[TBL] [Abstract][Full Text] [Related]
9. The effect of TNF-a antagonists on aortic stiffness and wave reflections: a meta-analysis.
Vlachopoulos C; Gravos A; Georgiopoulos G; Terentes-Printzios D; Ioakeimidis N; Vassilopoulos D; Stamatelopoulos K; Tousoulis D
Clin Rheumatol; 2018 Feb; 37(2):515-526. PubMed ID: 28484887
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
[TBL] [Abstract][Full Text] [Related]
11. Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study.
Angel K; Provan SA; Fagerhol MK; Mowinckel P; Kvien TK; Atar D
Am J Hypertens; 2012 Jun; 25(6):644-50. PubMed ID: 22378036
[TBL] [Abstract][Full Text] [Related]
12. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
Cacciapaglia F; Anelli MG; Rinaldi A; Serafino L; Covelli M; Scioscia C; Iannone F; Lapadula G
Drug Dev Res; 2014 Nov; 75 Suppl 1():S77-80. PubMed ID: 25381986
[TBL] [Abstract][Full Text] [Related]
13. Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis.
Kapoor SR; Filer A; Fitzpatrick MA; Fisher BA; Taylor PC; Buckley CD; McInnes IB; Raza K; Young SP
Arthritis Rheum; 2013 Jun; 65(6):1448-56. PubMed ID: 23460124
[TBL] [Abstract][Full Text] [Related]
14. Etanercept improves inflammation-associated arterial stiffness in rheumatoid arthritis.
Galarraga B; Khan F; Kumar P; Pullar T; Belch JJ
Rheumatology (Oxford); 2009 Nov; 48(11):1418-23. PubMed ID: 19734293
[TBL] [Abstract][Full Text] [Related]
15. Tocilizumab monotherapy reduces arterial stiffness as effectively as etanercept or adalimumab monotherapy in rheumatoid arthritis: an open-label randomized controlled trial.
Kume K; Amano K; Yamada S; Hatta K; Ohta H; Kuwaba N
J Rheumatol; 2011 Oct; 38(10):2169-71. PubMed ID: 21807781
[TBL] [Abstract][Full Text] [Related]
16. No significant changes in arterial stiffness in patients with ankylosing spondylitis after tumour necrosis factor alpha blockade treatment for 6 and 12 months.
Mathieu S; Pereira B; Couderc M; Rabois E; Dubost JJ; Soubrier M
Rheumatology (Oxford); 2013 Jan; 52(1):204-9. PubMed ID: 23065359
[TBL] [Abstract][Full Text] [Related]
17. Vascular inflammation and aortic stiffness: potential mechanisms of increased vascular risk in chronic obstructive pulmonary disease.
Fisk M; Cheriyan J; Mohan D; McEniery CM; Forman J; Cockcroft JR; Rudd JHF; Tal-Singer R; Hopkinson NS; Polkey MI; Wilkinson IB
Respir Res; 2018 May; 19(1):100. PubMed ID: 29793484
[TBL] [Abstract][Full Text] [Related]
18. [Are there any positive effects of TNF-alpha blockers on bone metabolism?].
Seriolo B; Paolino S; Sulli A; Cutolo M
Reumatismo; 2006; 58(3):199-205. PubMed ID: 17013436
[TBL] [Abstract][Full Text] [Related]
19. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of ascending aorta wall in rheumatoid arthritis by tissue and strain Doppler imaging during anti-tumor necrosis factor-α therapy.
Vizzardi E; Cavazzana I; Sciatti E; Bonadei I; D'Aloia A; Tincani A; Franceschini F; Metra M
Clin Cardiol; 2014 Dec; 37(12):738-43. PubMed ID: 25236839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
